Clinical trial

Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma

NCT07636252

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2023-06-14

PhaseN/A

Study timeline

Study start (actual)2023-06-14Date precision: day

Registry last updated2026-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Adenocarcinomaunresolved

Malignant Pleural Effusions (Mpe)unresolved

Interventions

Non-Interventional StudyOTHER

Sponsors & collaborators

Sheba Medical Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07636252 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.